Infinity Pharmaceuticals, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 21 rows in 2008. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2008-12-04: Reporting owner Lindblom Christopher M; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2008-12-04: Reporting owner Perkins Adelene Q; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2008-12-04: Reporting owner Perkins Adelene Q; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2008-12-04: Reporting owner ADAMS JULIAN; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2008-12-04 | Lindblom Christopher M Officer (Assistant Treasurer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,555 7,555 owned after | $7.18 exercise price | 2008-12-08 | |
| 2008-12-04 | Perkins Adelene Q Officer (Pres & Chief Business Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +110,000 110,000 owned after | $7.18 exercise price | 2008-12-08 | |
| 2008-12-04 | Perkins Adelene Q Officer (Pres & Chief Business Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +130,000 130,000 owned after | $7.18 exercise price | 2008-12-08 | |
| 2008-12-04 | ADAMS JULIAN Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +110,000 110,000 owned after | $7.18 exercise price | 2008-12-08 | |
| 2008-12-04 | Holtzman Steven H Director, Officer (CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +160,000 160,000 owned after | $7.18 exercise price | 2008-12-08 | |
| 2008-10-28 | ADAMS JULIAN Officer (President, R&D & CSO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −54,727 0 owned after | $2.04 exercise price | 2008-10-30 | |
| 2008-10-28 | ADAMS JULIAN Officer (President, R&D & CSO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −54,727 0 owned after | $2.04 exercise price | 2008-10-30 | |
| 2008-10-28 | ADAMS JULIAN Officer (President, R&D & CSO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −331 0 owned after | $3.48 exercise price | 2008-10-30 | |
| 2008-10-28 | ADAMS JULIAN Officer (President, R&D & CSO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −27,628 0 owned after | $3.48 exercise price | 2008-10-30 | |
| 2008-10-27 | Holtzman Steven H Director, Officer (CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −55,257 0 owned after | $2.04 exercise price | 2008-10-29 | |
| 2008-10-27 | Holtzman Steven H Director, Officer (CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −331 0 owned after | $3.48 exercise price | 2008-10-29 | |
| 2008-10-27 | Holtzman Steven H Director, Officer (CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −33,154 0 owned after | $3.48 exercise price | 2008-10-29 | |
| 2008-10-23 | SMITH IAN F Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,750 3,750 owned after | $5.48 exercise price | 2008-10-27 | |
| 2008-07-31 | Lindblom Christopher M Officer (Assistant Treasurer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $7.54 exercise price | 2008-08-04 | |
| 2008-05-22 | EVNIN ANTHONY B Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,375 9,375 owned after | $7.70 exercise price | 2008-05-23 | |
| 2008-05-22 | Babler Martin Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,375 9,375 owned after | $7.70 exercise price | 2008-05-23 | |
| 2008-05-22 | Lee Patrick Pak-Tin Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,750 3,750 owned after | $7.70 exercise price | 2008-05-23 | |
| 2008-05-22 | SATO VICKI L Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,875 1,875 owned after | $7.70 exercise price | 2008-05-23 | |
| 2008-05-22 | SMITH IAN F Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,375 9,375 owned after | $7.70 exercise price | 2008-05-23 | |
| 2008-05-22 | VENUTI MICHAEL C Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,750 3,750 owned after | $7.70 exercise price | 2008-05-23 | |
| 2008-01-02 | Lee Patrick Pak-Tin Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,750 3,750 owned after | $9.55 exercise price | 2008-01-03 |